METiS Technologies Secures Series D Funding for AI-Driven Nanodelivery

August 05, 2025
METiS Technologies has completed a RMB 400 million Series D financing round, co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund, to advance its AI-driven nanodelivery platform.

METiS Technologies has successfully closed a RMB 400 million Series D financing round, announced in a press release. The funding was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. This capital injection will be used to accelerate METiS' strategic initiatives, including automation upgrades to its proprietary platform, in-house pipeline development, and expansion of global partnerships.

The financing round was announced at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a significant hub for Beijing's life sciences sector. The funds will also support the recruitment of world-class talent, further enhancing METiS' capabilities in AI-driven nanodelivery innovation.

METiS Technologies is at the forefront of AI and nanomaterial science, focusing on transforming the delivery and application of active agents across various life forms. The company's proprietary platforms, such as AiLNP, AiRNA, and AiTEM, simulate and predict nanoscale interactions to optimize the design and validation of next-generation nanomaterials.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

08/09
Somnigroup Acquires Stake in Fullpower-AI, Extends Partnership
08/09
Andreessen Horowitz Leads $200 Million Investment in Periodic Labs
08/09
SoftBank Acquires Ohio Plant for AI Data Center Project
08/09
D-Tools Secures $12M Series C Funding to Enhance AI Capabilities
08/09
Casap Secures $25M Series A to Enhance AI-Powered Payment Dispute Resolution

More from: Life Sciences

08/11
HistoIndex Launches AI-Based FibroSIGHT Plus for Enhanced Fibrosis Assessment
08/09
Body Vision Medical's LungVision Approved in Singapore for Lung Cancer Diagnosis
08/09
Pager Health Introduces AI-Powered Behavioral Health Agent
08/09
ARMR Sciences Launches $30M Capital Raise for Biodefense Platform
08/09
Ellipsis Health Joins CMS Health Tech Ecosystem for AI Transformation

Subscribe to AI Funding Brief

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like